{
    "nctId": "NCT06088056",
    "briefTitle": "A Phase II Study of T-DXd Plus SRT in HER2-positive Breast Cancer Brain Metastases",
    "officialTitle": "A Phase II Study of T-DXd Plus Stereotactic Radiotherapy(SRT) in HER2-positive Breast Cancer Brain Metastases",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Breast Cancer, Brain Metastases, Radiotherapy",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 17,
    "primaryOutcomeMeasure": "Intracranial objective response rate(IC-ORR)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Pathologically confirmed HER2 positive advanced breast cancer\n* Age\\>18 years.\n* Brain metastases confirmed by enhanced brain MRI. Metastases number less than 15.\n* KPS\u226570 or KPS \u226560 with neurologic symptoms caused by BM\n* Life expectancy of more than 6 months\n* Prior therapy of oral dexamethasone not exceeding 16mg/d\n* Time interval from prior therapy was more than 2 weeks, and evaluation of adverse events is no more than grade 1.\n* Screening laboratory values must meet the following criteria( and should be obtained within 28 days prior to registration):\n\n  1. Absolute Neutrophil Count (ANC) \u2265 1.5 x 109/L, Platelets\u2265 90 x 109/L, Hemoglobin \u2265 90 g/L\n  2. Aspartate aminotransferase/alanine aminotransferase (AST/ALT) \u22642.5 x ULN without liver metastasis,\u2264 5 x ULN with liver metastases\n  3. Serum BUN and creatinine \u2264 1.5 x Upper Limit of Normal (ULN)\n  4. LVEF \u2265 50%\n  5. QTcF \\< 480 ms\n  6. INR\u22641.5\u00d7ULN\uff0cAPTT\u22641.5\u00d7ULN\n* Signed the informed consent form prior to patient entry\n\nExclusion Criteria:\n\n* Leptomeningeal or hemorrhagic metastases\n* Uncontrolled epilepsy\n* Severe or uncontrolled disease: severe cardiovascular disease, end-stage renal disease, severe hepatic disease, history of immunodeficiency, including HIV positive, active HBV/HCV or other acquired congenital immunodeficiency disease, or organ transplantation history, active infection, etc.\n* History of allergy to treatment regimens\n* Pregnancy or lactation period\uff0c women of child-bearing age who are unwilling to accept contraceptive measures.\n* Inability to complete enhanced MRI\n* Not suitable for inclusion for specific reasons judged by sponsor",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}